title: Lack of funding will inhibit evidence based commissioning of cancer treatments.
authors.forename: J
authors.initials: J
authors.lastname: So
authors.forename: J H
authors.initials: JH
authors.lastname: Scarffe
authors.forename: E
authors.initials: E
authors.lastname: Rous
authors.forename: R
authors.initials: R
authors.lastname: Foy
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D019317:Evidence-Based Medicine; D005381:Financing, Organized; D006801:Humans; D009369:Neoplasms / Q000191:economics*
chemical_list: D000970:Antineoplastic Agents